Log in or Sign up for Free to view tailored content for your specialty!
Myeloproliferative Neoplasms News
Eight noteworthy FDA actions
The FDA announced several decisions related to hematology and oncology therapies and devices in the past month.
Patient education pivotal when recommending palliative care
Patients with cancer who are educated about the benefits of palliative care are more likely to consider incorporating it into their treatment, according to results of a study by the American Psychological Association.
Log in or Sign up for Free to view tailored content for your specialty!
FDA grants marketing authorization to genomic sequencing kit for suspected polycythemia vera
The FDA granted marketing authorization to ipsogen JAK2 RGQ PCR Kit for the detection of mutations affecting the JAK2 gene, according to the device’s manufacturer.
Physician-aided deaths continue to rise in Oregon
The number of prescriptions written for physician-aided deaths in Oregon has increased annually since it became the first state to enact the Death with Dignity Act in 1997, according to a retrospective cohort study published in JAMA Oncology.
ASCO: Coordinated effort needed to provide high-quality care to sexual and gender minorities
Sexual and gender minorities diagnosed with cancer may encounter specific challenges, including discrimination and greater risks for anxiety and depression, according to an ASCO guideline published in Journal of Clinical Oncology.
Biden: Cancer moonshot has ‘evolved from program to movement’
International and private sector collaboration, as well as the $1.8 billion in federal funding directed toward the NIH as part of the 21st Century Cures Act, are two major accomplishments of the national cancer moonshot initiative achieved in the past year, according to former Vice President Joe Biden.
Annual report: Overall cancer death rates continue to decline, but problem areas persist
Overall cancer death rates continued to decrease in men, women and children among all racial and ethnic groups, according to the Annual Report to the Nation on the Status of Cancer.
‘We can do better’: ASCO report outlines persistent health care disparities, need for funding
Over the next 10 years, the number of cancer survivors in the United States is expected to grow from 15.5 million to 20.3 million, according to ASCO’s State of Cancer Care in America: 2017 report released today.
Leading cancer organizations: Trump’s proposed NIH budget cuts will threaten research, patient care
Many of the nation’s leading research organizations and cancer centers have voiced their opposition to President Donald J. Trump’s proposed budget, which includes a $5.8 billion cut to NIH funding in 2018.
Open-access ‘knowledgebase’ focuses on clinical relevance of cancer gene mutations
Cancer researchers at Washington University School of Medicine in St. Louis have developed an online cancer database designed to streamline the sharing of tumor-related genetic information.